In a more recent work, Choi and coworkers showed that vaccines based on DCs pulsed with EpCAM peptides elicit a strong antigen-specific CTL response and result in a significant suppression of tumor growth in a mouse model. The gene discussed is EPCAM; the disease is neoplasm.